Article
A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
Stem cell research - 1 Apr 2022
Zhao Xi, Cao Jinhua, Li Xiaowei, Liu Mengduan, Liu Yangyang, Dong Jianzeng, Zhao Xiaoyan
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is the most common heterogeneous myocardial disease. MYBPC3 variants are the leading cause of HCM. In the present study, a human induced pluripotent stem cell (iPSC) line ZZUNEUi025-A was generated from peripheral blood mononuclear cells of a male HCM patient with c. 772+1G > A in MYBPC3 gene. This cell line expressed pluripotency markers, had normal male karyotype and could...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
